Target intelligence / Profile preview

Bacterial 23S ribosomal RNA (23S rRNA) (23S rRNA)

Target
23S rRNA
Molecular classification
Ribosomal RNA, Ribozyme, Nucleic acid
01

Overview

The bacterial 23S ribosomal RNA (rRNA) is the primary catalytic and structural component of the 50S large ribosomal subunit in prokaryotes (Wilson, 2014, Nature Reviews Microbiology). It forms the peptidyl transferase center (PTC), which is responsible for catalyzing the formation of peptide bonds during protein synthesis (Polikanov et al., 2014, Molecular Cell). Extending from the PTC is the nascent peptide exit tunnel (NPET), a channel composed largely of 23S rRNA through which the growing polypeptide chain must pass to exit the ribosome (Arenz & Wilson, 2016, Cold Spring Harbor Perspectives in Biology). This tunnel is a major pharmacological target for several classes of antibiotics, including macrolides, lincosamides, and oxazolidinones (Dunkle et al., 2010, PNAS). These drugs bind to specific sites on the 23S rRNA, often near the constriction point of the tunnel, to physically obstruct the passage of the nascent peptide or inhibit the catalytic activity of the PTC (Vester & Douthwaite, 2001, Antimicrobial Agents and Chemotherapy). Because the 23S rRNA is highly conserved across bacterial species, it serves as a broad-spectrum target, though mutations or modifications like methylation can lead to significant clinical resistance (Munita & Arias, 2016, Microbiology Spectrum). Understanding the structural interactions within the NPET is crucial for developing next-generation antibiotics that can overcome these resistance mechanisms.

Other names
23S rRNALarge ribosomal subunit RNA50S ribosomal RNA componentPeptidyl transferase center RNANascent peptide exit tunnel RNA
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the 23S rRNA within the nascent peptide exit tunnel (NPET) or the peptidyl transferase center (PTC), which physically blocks the elongation of the nascent polypeptide chain or prevents peptide bond formation (Wilson, 2014; Polikanov et al., 2014).

03

Biological functions

Protein synthesisPeptidyl transferase activityNascent peptide transportTranslation elongation
04

Disease associations

Bacterial infection
05

Safety considerations

Mitochondrial ribosome inhibition leading to myelosuppression, lactic acidosis, or neuropathyDevelopment of multidrug resistance (e.g., MRSA, VRE)Disruption of the commensal microbiome and risk of Clostridioides difficile infection
06

Interacting drugs

Erythromycin

9 more in the full profile.

07

Biomarkers

23S rRNA A2058 mutation23S rRNA A2059 mutationErm-mediated A2058 dimethylationCfr-mediated A2503 methylation

Beyond the preview

Go deeper on Bacterial 23S ribosomal RNA (23S rRNA) (23S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 23S ribosomal RNA (23S rRNA) (23S rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call